ONEMEDNET CORPORATION Increase (Decrease) in Deferred Revenue
ONEMEDNET CORPORATION (ONMD) reported Increase (Decrease) in Deferred Revenue of $294.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-14
- ONEMEDNET CORPORATION increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was $4.00K, a 55.56% decline year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $290.00K.
- ONEMEDNET CORPORATION increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$381.00K, a 386.47% decline year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $258.00K.
- ONEMEDNET CORPORATION increase (decrease) in deferred revenue for fiscal 2023 was $70.00K.
- ONEMEDNET CORPORATION increase (decrease) in deferred revenue for fiscal 2022 was -$458.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $4.00K derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | $294.00K 10-Q · filed 2026-08-14 | -$87.00K derived: sum of 3 quarters · filed 2026-08-14 | $171.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $290.00K S-1/A · filed 2026-07-08 | -$91.00K derived: sum of 2 quarters · filed 2026-07-08 | $167.00K derived: sum of 3 quarters · filed 2026-07-08 | $176.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$381.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | -$123.00K derived: sum of 2 quarters · filed 2026-07-08 | -$114.00K derived: sum of 3 quarters · filed 2026-08-14 | -$172.00K S-1/A · filed 2026-07-08 | |
| 2025-09-30 | $258.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $267.00K derived: sum of 2 quarters · filed 2026-08-14 | $209.00K 10-Q · filed 2025-11-14 | $342.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $9.00K derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | -$49.00K 10-Q · filed 2026-08-14 | $84.00K derived: sum of 3 quarters · filed 2026-08-14 | -$7.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$58.00K S-1/A · filed 2026-07-08 | $75.00K derived: sum of 2 quarters · filed 2026-07-08 | -$16.00K derived: sum of 3 quarters · filed 2026-07-08 | $47.00K derived: sum of 4 quarters · filed 2026-07-08 | |
| 2024-12-31 | $133.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $42.00K derived: sum of 2 quarters · filed 2026-07-08 | $105.00K derived: sum of 3 quarters · filed 2026-07-08 | $307.00K S-1/A · filed 2026-07-08 | |
| 2024-09-30 | -$91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$28.00K derived: sum of 2 quarters · filed 2025-11-14 | $174.00K 10-Q · filed 2025-11-14 | $16.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $265.00K 10-Q · filed 2025-08-13 | $107.00K derived: sum of 3 quarters · filed 2025-08-13 | $57.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $202.00K 10-Q · filed 2025-05-14 | $44.00K derived: sum of 2 quarters · filed 2025-05-14 | -$6.00K derived: sum of 3 quarters · filed 2025-05-14 | $181.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$208.00K derived: sum of 2 quarters · filed 2025-04-15 | -$21.00K derived: sum of 3 quarters · filed 2025-04-15 | $70.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $137.00K derived: sum of 2 quarters · filed 2024-12-17 | $228.00K 10-Q · filed 2024-12-17 | $210.10K 10-Q · filed 2023-11-20 | -$33.00K derived: sum of 4 quarters · filed 2024-12-17 |
| 2023-06-30 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-11 | $278.00K 10-Q · filed 2024-12-11 | $17.00K derived: sum of 3 quarters · filed 2024-12-11 | ||
| 2023-03-31 | $91.00K 10-Q · filed 2024-12-05 | -$170.00K derived: sum of 2 quarters · filed 2024-12-05 | |||
| 2022-12-31 | -$261.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | -$458.00K 10-K/A · filed 2024-11-05 | |||
| 2022-09-30 | -$197.00K 8-K/A · filed 2024-11-22 | -$306.89K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |